Evidence map›Paper›PMID 40595110›Full record

Observational studyScientific reports2025

Initial report of prospective study of regional cooperation for imaging-based follow-up after curative renal cell carcinoma surgery.

Ryo Tsukamoto, Tomokazu Sazuka, Hiroaki Sato, Takayuki Arai, Manato Kanesaka, Keisuke Ando, Yasutaka Yamada, Yusuke Goto, Yusuke Imamura, Shinichi Sakamoto and 9 more

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Ryo Tsukamoto *Department of Urology, Graduate School of Medicine, Chiba University Hospital, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Tomokazu Sazuka *Department of Urology, Graduate School of Medicine, Chiba University Hospital, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan. tomo1ata2@yahoo.co.jp.
Hiroaki SatoDepartment of Urology, Graduate School of Medicine, Chiba University Hospital, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Takayuki AraiDepartment of Urology, Graduate School of Medicine, Chiba University Hospital, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Manato KanesakaDepartment of Urology, Graduate School of Medicine, Chiba University Hospital, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Keisuke AndoDepartment of Urology, Graduate School of Medicine, Chiba University Hospital, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Yasutaka YamadaDepartment of Urology, Graduate School of Medicine, Chiba University Hospital, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Yusuke GotoDepartment of Urology, Graduate School of Medicine, Chiba University Hospital, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Yusuke ImamuraDepartment of Urology, Graduate School of Medicine, Chiba University Hospital, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Shinichi SakamotoDepartment of Urology, Graduate School of Medicine, Chiba University Hospital, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Junryo RiiDepartment of Urology, Graduate School of Medicine, Chiba University Hospital, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Hiroaki KuramochiDepartment of Urology, Graduate School of Medicine, Chiba University Hospital, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Kensei MiyamotoDepartment of Urology, Graduate School of Medicine, Chiba University Hospital, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Yasuhiro ShigetaDepartment of Urology, Graduate School of Medicine, Chiba University Hospital, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Kazuhiro SuzukiDepartment of Urology, Graduate School of Medicine, Chiba University Hospital, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Masashi YanoDepartment of Urology, Graduate School of Medicine, Chiba University Hospital, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Masahiro MinamideDepartment of Urology, Graduate School of Medicine, Chiba University Hospital, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Takeya MiyauchiDepartment of Urology, Graduate School of Medicine, Chiba University Hospital, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Tomohiko IchikawaDepartment of Urology, Graduate School of Medicine, Chiba University Hospital, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Late recurrence of renal cell carcinoma (RCC) is observed in some postoperative patients. In addition, some of these patients do not continue postoperative follow-up. Improving the regular follow-up process for the increased convenience of patients is expected. This aimed to assess the follow-up of patients after surgery for RCC. We initiated the relationship between Chiba University Hospital and Clinics project, which is ongoing. In this prospective, observational study, postoperative patients were asked to attend follow-ups in urology clinics. Imaging was performed at nearby imaging clinics. A total of 404 patients with RCC who underwent radical and/or partial nephrectomy were included in this analysis. A total of 283 patients continued follow-up at university hospitals and 121 patients were followed up in clinics. The median follow-up was 12.4 months. Patients with a long postoperative observation period tended to request continued follow-up at a university hospital. Patients living in municipalities with affiliated clinics were more likely to request follow-up at these clinics. The total loss to follow-up rate was lower than previous data showed. Comprehensive QOL and serum creatinine concentrations were not decreased in clinic group. This is the first study successfully collaborated with clinics in follow-up observation after RCC surgery.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsAdultAgedAged, 80 and overFemaleFollow-Up StudiesHumansMaleMiddle AgedNeoplasm Recurrence, LocalNephrectomyProspective StudiesQuality of LifeClinicFollow-upProspective studyRegional cooperationRenal cell carcinoma

Identifiers

PMID40595110
PMCPMC12216881

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.